These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3302121)

  • 1. Adjuvant treatment of Parksinson's disease with budipine: a double-blind trial versus placebo.
    Jellinger K; Bliesath H
    J Neurol; 1987 Jun; 234(5):280-2. PubMed ID: 3302121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tremorlytic activity of budipine in Parkinson's disease.
    Spieker S; Eisebitt R; Breit S; Przuntek H; Müller D; Klockgether T; Dichgans J
    Clin Neuropharmacol; 1999; 22(2):115-9. PubMed ID: 10202609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.
    Przuntek H; Bittkau S; Bliesath H; Büttner U; Fuchs G; Glass J; Haller H; Klockgether T; Kraus P; Lachenmayer L; Müller D; Müller T; Rathay B; Sgonina J; Steinijans V; Teshmar E; Ulm G; Volc D
    Arch Neurol; 2002 May; 59(5):803-6. PubMed ID: 12020263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tremorlytic activity of budipine in Parkinson's disease.
    Spieker S; Breit S; Klockgether T; Dichgans J
    J Neural Transm Suppl; 1999; 56():165-72. PubMed ID: 10370910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monotherapy of Parkinson's disease with budipine. A double blind comparison with amantadine].
    Malsch U; Bliesath H; Böther K; Ramm H; Lühmann R
    Fortschr Neurol Psychiatr; 2001 Feb; 69(2):86-9. PubMed ID: 11253562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of budipine in Parkinson's disease.
    Przuntek H; Müller T
    J Neural Transm Suppl; 1999; 56():75-82. PubMed ID: 10370903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tremorlytic activity of budipine: a quantitative study with long-term tremor recordings.
    Spieker S; Löschmann P; Jentgens C; Boose A; Klockgether T; Dichgans J
    Clin Neuropharmacol; 1995 Jun; 18(3):266-72. PubMed ID: 8635185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modification of Parkinson tremor by budipine. A comparative study with amantadine].
    Iizuka J; Fischer R
    Nervenarzt; 1986 Mar; 57(3):184-6. PubMed ID: 3515215
    [No Abstract]   [Full Text] [Related]  

  • 9. Budipine in Parkinson's tremor.
    Reichmann H
    J Neurol Sci; 2006 Oct; 248(1-2):53-5. PubMed ID: 16784759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesulergine in early Parkinson's disease: a double blind controlled trial.
    Dupont E; Mikkelsen B; Jakobsen J
    J Neurol Neurosurg Psychiatry; 1986 Apr; 49(4):390-5. PubMed ID: 3517235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of budipine and placebo in untreated patients with Parkinson's disease.
    Müller T; Kuhn W; Przuntek H
    J Neural Transm (Vienna); 2005 Aug; 112(8):1015-23. PubMed ID: 15583956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
    Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
    CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients.
    Baas H; Beiske AG; Ghika J; Jackson M; Oertel WH; Poewe W; Ransmayr G
    Neurology; 1998 May; 50(5 Suppl 5):S46-53. PubMed ID: 9591522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients.
    Kumar R; Hauser RA; Mostillo J; Dronamraju N; Graf A; Merschhemke M; Kenney C
    Int J Neurosci; 2016; 126(1):20-4. PubMed ID: 24007304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
    Rascol O; Brooks DJ; Melamed E; Oertel W; Poewe W; Stocchi F; Tolosa E;
    Lancet; 2005 Mar 12-18; 365(9463):947-54. PubMed ID: 15766996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa and the progression of Parkinson's disease.
    Fahn S; Oakes D; Shoulson I; Kieburtz K; Rudolph A; Lang A; Olanow CW; Tanner C; Marek K;
    N Engl J Med; 2004 Dec; 351(24):2498-508. PubMed ID: 15590952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial.
    Ferreira JJ; Lees A; Rocha JF; Poewe W; Rascol O; Soares-da-Silva P;
    Lancet Neurol; 2016 Feb; 15(2):154-165. PubMed ID: 26725544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease.
    Ferreira JJ; Rocha JF; Falcão A; Santos A; Pinto R; Nunes T; Soares-da-Silva P
    Eur J Neurol; 2015 May; 22(5):815-25, e56. PubMed ID: 25649051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom.
    Lees AJ
    BMJ; 1995 Dec; 311(7020):1602-7. PubMed ID: 8555803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.